Tanya Stoyanova

Tanya Stoyanova

Stanford University

H-index: 24

North America-United States

About Tanya Stoyanova

Tanya Stoyanova, With an exceptional h-index of 24 and a recent h-index of 21 (since 2020), a distinguished researcher at Stanford University, specializes in the field of Cancer biology, cancer therapies, cancer early detection, cancer imaging.

His recent articles reflect a diverse array of research interests and contributions to the field:

UCHL1 is a potential molecular indicator and therapeutic target for neuroendocrine carcinomas

UCHL1 is a molecular indicator and a therapeutic target for neuroendocrine carcinomas

High expression of Trop2 is associated with aggressive localized prostate cancer and is a candidate urinary biomarker

CXCR4/CB2 heterodimer antagonizes CXCR4-mediated metastasis and tumor growth in vivo

CDC7 is a targetable regulator of advanced prostate cancer

Shed Trop2 drives prostate cancer progression and Trop2 is a novel tissue prognostic biomarker and a candidate urinary marker for prostate cancer

Co-axial hydrogel spinning for facile biofabrication of prostate cancer-like 3D models

Proteomics analysis of urine and catheter-associated biofilms in spinal cord injury patients

Tanya Stoyanova Information

University

Position

Assistant Professor of Radiology

Citations(all)

3201

Citations(since 2020)

2222

Cited By

1623

hIndex(all)

24

hIndex(since 2020)

21

i10Index(all)

40

i10Index(since 2020)

37

Email

University Profile Page

Stanford University

Google Scholar

View Google Scholar Profile

Tanya Stoyanova Skills & Research Interests

Cancer biology

cancer therapies

cancer early detection

cancer imaging

Top articles of Tanya Stoyanova

Title

Journal

Author(s)

Publication Date

UCHL1 is a potential molecular indicator and therapeutic target for neuroendocrine carcinomas

Cell Reports Medicine

Shiqin Liu

Timothy Chai

Fernando Garcia-Marques

Qingqing Yin

En-Chi Hsu

...

2024/1/19

UCHL1 is a molecular indicator and a therapeutic target for neuroendocrine carcinomas

Cancer Research

Shiqin Liu

Timothy Chai

Fernando Marques

Qingqing Yin

En-Chi Hsu

...

2024/3/22

High expression of Trop2 is associated with aggressive localized prostate cancer and is a candidate urinary biomarker

Scientific reports

Shiqin Liu

Sarah J Hawley

Christian A Kunder

En-Chi Hsu

Michelle Shen

...

2024/1/4

CXCR4/CB2 heterodimer antagonizes CXCR4-mediated metastasis and tumor growth in vivo

Cancer Research

Nakea Michelle Pennant

Alifiani B Hartono

Shiqin Liu

Christopher Massey

Chung Lee

...

2024/3/22

CDC7 is a targetable regulator of advanced prostate cancer

Cancer Research

Alifiani Bonita Hartono

Sidharth Paparaju

Chung Lee

Shiqin Liu

Busola R Alabi

...

2024/3/22

Shed Trop2 drives prostate cancer progression and Trop2 is a novel tissue prognostic biomarker and a candidate urinary marker for prostate cancer

Cancer Research

Shiqin Liu

Sarah Hawley

Christian Kunder

En-Chi Hsu

Michelle Shen

...

2024/3/22

Co-axial hydrogel spinning for facile biofabrication of prostate cancer-like 3D models

Biofabrication

Carlos F Guimarães

Shiqin Liu

Jie Wang

Emma Purcell

Tugba Ozedirne

...

2024/2/2

Proteomics analysis of urine and catheter-associated biofilms in spinal cord injury patients

American Journal of Clinical and Experimental Urology

Fernando J Garcia-Marques

Elissa Zakrasek

Abel Bermudez

Alexandra L Polasko

Shiqin Liu

...

2023

ACAA2 is a novel molecular indicator for cancers with neuroendocrine phenotype

British Journal of Cancer

Michelle Shen

Shiqin Liu

Angus Toland

En-Chi Hsu

Alifiani B Hartono

...

2023/11/23

Dual-inhibitory domain iCARs improve the efficiency of the AND-NOT gate CAR T strategy

Proceedings of the National Academy of Sciences

Nathanael J Bangayan

Liang Wang

Giselle Burton Sojo

Miyako Noguchi

Donghui Cheng

...

2023/11/21

Multimodal in vivo tracking of chimeric antigen receptor T cells in preclinical glioblastoma models

Investigative Radiology

Wei Emma Wu

Edwin Chang

Linchun Jin

Shiqin Liu

Ching-Hsin Huang

...

2023

Naoki Matsumura1, Kazutoshi Fujita2*, Mitsuhisa Nishimoto2, Yutaka Yamamoto3, Ken Kuwahara4, Yasuharu Nagai 5, Takafumi Minami2, Yuji Hatanaka6, Masahiro Nozawa2, Yasuhiro …

Advances in Prostate Cancer: Model Systems, Molecular and Cellular Mechanisms, Early Detection, and Therapies

Tanya I Stoyanova

Andrew Protheroe

Shiqin Liu

2022/8/8

Metastasis Model to Test the Role of Notch Signaling in Prostate Cancer

Shiqin Liu

En-chi Hsu

Michelle Shen

Merve Aslan

Tanya Stoyanova

2022/6/9

Volbots: Volvox Microalgae‐Based Robots for Multimode Precision Imaging and Therapy

Advanced Functional Materials

Jie Wang

Fernando Soto

Shiqin Liu

Qingqing Yin

Emma Purcell

...

2022/12

Acoustic fabrication of living cardiomyocyte-based hybrid biorobots

ACS nano

Jie Wang

Fernando Soto

Peng Ma

Rajib Ahmed

Huaxiao Yang

...

2022/6/7

Correlation of 68Ga-RM2 PET with postsurgery histopathology findings in patients with newly diagnosed intermediate-or high-risk prostate cancer

Journal of Nuclear Medicine

Heying Duan

Lucia Baratto

Richard E Fan

Simon John Christoph Soerensen

Tie Liang

...

2022/12/1

Protein signatures to distinguish aggressive from indolent prostate cancer

The Prostate

Fernando Garcia‐Marques

Shiqin Liu

Sarah M Totten

Abel Bermudez

Cheylene Tanimoto

...

2022/4

Molecular mechanisms underlying the development of neuroendocrine prostate cancer

Shiqin Liu

Busola Ruth Alabi

Qingqing Yin

Tanya Stoyanova

2022/11/1

SU086, an inhibitor of HSP90, impairs glycolysis and represents a treatment strategy for advanced prostate cancer

Cell Reports Medicine

Meghan A Rice

Vineet Kumar

Dhanir Tailor

Fernando Jose Garcia-Marques

En-Chi Hsu

...

2022/2/15

Current and emerging therapies for neuroendocrine prostate cancer

Busola Ruth Alabi

Shiqin Liu

Tanya Stoyanova

2022/10/1

See List of Professors in Tanya Stoyanova University(Stanford University)